Cargando…

Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy

Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterized by a progressive loss of strength. Important deficits in cognitive functioning and a significant prevalence of psychiatric disorders have been previously reported. Methods:A neuropsychological and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Callus, Edward, Bertoldo, Enrico G., Beretta, Maria, Boveri, Sara, Cardani, Rosanna, Fossati, Barbara, Brigonzi, Elisa, Meola, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160752/
https://www.ncbi.nlm.nih.gov/pubmed/30298045
http://dx.doi.org/10.3389/fneur.2018.00751
_version_ 1783358835526729728
author Callus, Edward
Bertoldo, Enrico G.
Beretta, Maria
Boveri, Sara
Cardani, Rosanna
Fossati, Barbara
Brigonzi, Elisa
Meola, Giovanni
author_facet Callus, Edward
Bertoldo, Enrico G.
Beretta, Maria
Boveri, Sara
Cardani, Rosanna
Fossati, Barbara
Brigonzi, Elisa
Meola, Giovanni
author_sort Callus, Edward
collection PubMed
description Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterized by a progressive loss of strength. Important deficits in cognitive functioning and a significant prevalence of psychiatric disorders have been previously reported. Methods:A neuropsychological and psychological assessment was carried out in 31 DM1 patients (61% males) in order to measure the cognitive functioning and explore their personality profiles. The MMSE Mini-Mental State Examination, Frontal Assessment Battery (FAB), ENB-2 Battery assessing memory (short term, long term and working memory), integration capacities, visual-spatial ability, attention (selective, divided, shifting/switching) executive functions, praxis, discrimination and logic capabilities and psychopathology Symptom Check List 90-R (SCL-90-R) were administered. The neuropsychological and psychological evaluation of DM1 patients was carried out taking into consideration the clinical parameters (CTG repeat, age at onset, disease duration, Muscular Impairment Rate Scale (MIRS), Medical Research Council Scale (MRC) and the Epworth Sleepiness Scales (EPS)). Results: Regarding psychopathology 19.4% of patients scored a moderate or high level of symptoms intensity index (GSI), 12.9% reported a high number of symptoms (PST) and 16.1% reported a high intensity level of the perceived symptoms (PSDI). Fatigue and daytime sleepiness resulted as being associated with higher levels of psychoticism (PSY). Only 1 patient reported a severe impairment in the spatial and temporal orientation, memory, language, praxis, attention and calculation. Longer disease duration was also associated with cognitive impairment evaluated through ENB-2 (p < 0.05). Discussions and Conclusions:There are indications of the utility of neuropsychological and psychological screening and support for these patients and their families due to the link between disease duration and cognitive performances. A proposal of a clinical protocol, with an illustration of a clinical case report of a family is presented.
format Online
Article
Text
id pubmed-6160752
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61607522018-10-08 Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy Callus, Edward Bertoldo, Enrico G. Beretta, Maria Boveri, Sara Cardani, Rosanna Fossati, Barbara Brigonzi, Elisa Meola, Giovanni Front Neurol Neurology Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterized by a progressive loss of strength. Important deficits in cognitive functioning and a significant prevalence of psychiatric disorders have been previously reported. Methods:A neuropsychological and psychological assessment was carried out in 31 DM1 patients (61% males) in order to measure the cognitive functioning and explore their personality profiles. The MMSE Mini-Mental State Examination, Frontal Assessment Battery (FAB), ENB-2 Battery assessing memory (short term, long term and working memory), integration capacities, visual-spatial ability, attention (selective, divided, shifting/switching) executive functions, praxis, discrimination and logic capabilities and psychopathology Symptom Check List 90-R (SCL-90-R) were administered. The neuropsychological and psychological evaluation of DM1 patients was carried out taking into consideration the clinical parameters (CTG repeat, age at onset, disease duration, Muscular Impairment Rate Scale (MIRS), Medical Research Council Scale (MRC) and the Epworth Sleepiness Scales (EPS)). Results: Regarding psychopathology 19.4% of patients scored a moderate or high level of symptoms intensity index (GSI), 12.9% reported a high number of symptoms (PST) and 16.1% reported a high intensity level of the perceived symptoms (PSDI). Fatigue and daytime sleepiness resulted as being associated with higher levels of psychoticism (PSY). Only 1 patient reported a severe impairment in the spatial and temporal orientation, memory, language, praxis, attention and calculation. Longer disease duration was also associated with cognitive impairment evaluated through ENB-2 (p < 0.05). Discussions and Conclusions:There are indications of the utility of neuropsychological and psychological screening and support for these patients and their families due to the link between disease duration and cognitive performances. A proposal of a clinical protocol, with an illustration of a clinical case report of a family is presented. Frontiers Media S.A. 2018-09-19 /pmc/articles/PMC6160752/ /pubmed/30298045 http://dx.doi.org/10.3389/fneur.2018.00751 Text en Copyright © 2018 Callus, Bertoldo, Beretta, Boveri, Cardani, Fossati, Brigonzi and Meola. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Callus, Edward
Bertoldo, Enrico G.
Beretta, Maria
Boveri, Sara
Cardani, Rosanna
Fossati, Barbara
Brigonzi, Elisa
Meola, Giovanni
Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title_full Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title_fullStr Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title_full_unstemmed Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title_short Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
title_sort neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in italy
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160752/
https://www.ncbi.nlm.nih.gov/pubmed/30298045
http://dx.doi.org/10.3389/fneur.2018.00751
work_keys_str_mv AT callusedward neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT bertoldoenricog neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT berettamaria neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT boverisara neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT cardanirosanna neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT fossatibarbara neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT brigonzielisa neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly
AT meolagiovanni neuropsychologicalandpsychologicalfunctioningaspectsinmyotonicdystrophytype1patientsinitaly